Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of inc ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Cole Herlitz-Ferguson - Stern Investor Relations Derek Chalmers - President and Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Jessica Fye - J.P. Morgan Chris Howerton - Jefferies David Amsellem - Piper Sandler Jason Gerberry - Bank of America Jack Padovano - Stifel Oren Livnat - H.C. Wainwright Operator Good afternoon and welcome to the Cara The ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorpor ...

Targeting Pruritus with First-In-Class Therapeutics MAY 10, 2021 Forward Looking Statements Statements contained in this presentation regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forwardlooking statements include statements concerning the expected timing of the enrollment and data readouts from the Company's ongoing clinical trials, the potential results of ongoing clinical trial ...

Call Start: 16:30 January 1, 0000 5:11 PM ET Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2021 Earnings Conference Call May 10, 2021 16:30 ET Company Participants Jack Hildick-Smith - Investor Relations Derek Chalmers - Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Chris Howerton - Jefferies David Amsellem - Piper Sandler Joseph Stringer - Needham & Company Oren Livnat - H.C. Wainwright Operator Good afternoon and welcome to Cara Therapeutics First Quarter 2021 Fin ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorpo ...

Targeting Pruritus with First-In-Class Therapeutics February, 2021 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the words "anticipate," "believe," "continue," "estimate," "expect," "objective," "ongoing," "plan," "propose," "potential," "projected", or "up-coming" and/or the negative of these terms, or other comparable termino ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Jack Hildick-Smith - Stern IR Derek Chalmers - Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Avatar Jones - Stifel Financial Corp. Brian Mills - Jefferies Jason Gerberry - Bank of America Merrill Lynch Joseph Stringer - Needham & Company David Amsellem - Piper Sandler Benedict Shim - Canaccord Genuity LLC Operator Good afternoon and welcome t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorporation or organ ...

Targeting Pruritus with First-In-Class Therapeutics January, 2021 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the words "anticipate," "believe," "continue," "estimate," "expect," "objective," "ongoing," "plan," "propose," "potential," "projected", or "up-coming" and/or the negative of these terms, or other comparable terminol ...